ADMA Biologics Inc vs Angi Inc — how do they compare? ADMA Biologics Inc trades at $9.87 (market cap $2.22B), while Angi Inc trades at $4.55 (market cap $182.30M). The key difference: ADMA Biologics Inc is far larger — about 12.2× Angi Inc's market cap, and ADMA Biologics Inc is trading nearer its 52-week high, Angi Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | ANGI | |
|---|---|---|
Market Cap | $2.22B | $182.30M |
Sector | Health | Media |
52-Week High | $20.38 | $18.46 |
52-Week Low | $7.60 | $4.49 |
Enterprise Value | $2.29B | $392.07M |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Angi Inc connects quality home service professionals across different categories, from repairing and remodeling to cleaning and landscaping, with consumers. It has two geographical segments namely North America (the United States and Canada), which primarily includes the operations HomeAdvisor, Angie's List, Handy, mHelpDesk, HomeStars, and Fixd Repair
Read more on ANGI →